Developed in collaboration with leading clinicians, Philips' Vereos digital PET/CT system and IQon Spectral CT system1 are designed to create a short path to the best care and help improve patient care

CHICAGO /PRNewswire/ -- At the 99th Annual Meeting of the Radiological Society of North America (RSNA) in Chicago, Royal Philips (NYSE: PHG, AEX: PHIA) today illustrated its technology leadership in medical imaging with the introduction of two fundamentally new developments: its Vereos PET/CT fully digital positron emission tomography/computed tomography (PET/CT) imaging system, and its IQon Spectral CT1 spectral detector-based computed tomography (CT) imaging system.

These new innovations further expand Philips' integrated radiology product portfolio to deliver advanced image quality, critical information and connectivity for seamless real-time collaboration among clinicians and fast, confident decision making. Philips partners with clinicians to drive the clinical performance and economic value of its solutions to find the shortest path to the best care with the most efficient use of resources.
"We work closely with radiologists to understand their biggest challenges, and incorporate these understandings in the development of innovative products like Vereos PET/CT and IQon Spectral CT to meet their complex imaging needs," said Gene Saragnese, CEO, Imaging Systems at Philips Healthcare. "These innovations demonstrate how Philips is providing radiologists with exceptional quality and accuracy in imaging at low dose rates, helping clinicians to get answers, the first time around, so that they can deliver accurate and more confident diagnoses to patients."

"The timing and precision of disease diagnosis are critical to the successful treatment of many diseases," commented Pablo Ros, M.D., Chairman of the Department of Radiology, University Hospitals Case Medical Center and Case Western Reserve University, Cleveland, Ohio. "With that in mind, we are excited to have contributed to the development of Philips' Vereos digital PET/CT and IQon Spectral CT systems and we will continue to collaborate with Philips to realize the potential of these next generation imaging systems."

Vereos PET/CT
PET scans are three-dimensional images that provide insight into what is happening inside the body at the molecular and cellular level. A small amount of radiotracer is injected into the patient prior to the exam, which accumulates in the body's tissue and organs, and decays. The PET detector captures pairs of photons that are emitted from the body during this decay process and forms the image. Based on Philips' proprietary 'Digital Photon Counting' technology, the Vereos PET/CT is the first PET/CT system in the industry to use innovative digital silicon photomultiplier detectors instead of traditional analog detectors, resulting in a step change in performance that includes an approximately two-times increase in sensitivity gain, volumetric resolution and quantitative accuracy compared to analog systems.2 These radical improvements can ultimately be translated into high image quality, increased diagnostic confidence, improved treatment planning and faster workflows.

More HCB News